The Combination of Epigenetic Drugs SAHA and HCI-2509 Synergistically Inhibits EWS-FLI1 and Tumor Growth in Ewing Sarcoma

Oncotarget - United States
doi 10.18632/oncotarget.25829
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Impact Journals, LLC

Related search

Genomic EWS-FLI1 Fusion Sequences in Ewing Sarcoma Resemble Breakpoint Characteristics of Immature Lymphoid Malignancies

PLoS ONE
Multidisciplinary
2013English

EWS-FLI1 Regulates a Transcriptional Program in Cooperation With Foxq1 in Mouse Ewing Sarcoma

Cancer Science
Cancer ResearchMedicineOncology
2018English

18f-FLT Positron Emission Tomography (PET) Is a Pharmacodynamic Marker for EWS-FLI1 Activity and Ewing Sarcoma

Scientific Reports
Multidisciplinary
2016English

PTPL1 Is a Direct Transcriptional Target of EWS-FLI1 and Modulates Ewing's Sarcoma Tumorigenesis

Oncogene
Cancer ResearchGeneticsMolecular Biology
2005English

The Combination of Ulinastatin and 5-Fluorouracil Synergistically Inhibits Hepatocellular Carcinoma Growth

Journal of International Medical Research
BiochemistryMedicineCell Biology
2020English

EWSR1-FLI1 Activation of the Cancer/Testis Antigen FATE1 Promotes Ewing Sarcoma Survival

Molecular and Cellular Biology
Cell BiologyMolecular Biology
2019English

EWS/FLI Is a Master Regulator of Metabolic Reprogramming in Ewing Sarcoma

Molecular Cancer Research
Cancer ResearchOncologyMolecular Biology
2017English

Therapeutic Opportunities in Ewing Sarcoma: EWS-FLI Inhibition via LSD1 Targeting

Oncotarget
Oncology
2016English

Hypoxia Modulates EWS-FLI1 Transcriptional Signature and Enhances the Malignant Properties of Ewing's Sarcoma Cells in Vitro

Cancer Research
Cancer ResearchOncology
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy